Literature DB >> 4159124

Enzyme stimulation and inhibition in the metabolism of drugs.

J J Burns, A H Conney.   

Abstract

Studies in recent years have disclosed two types of drug interaction which may be important in drug therapy:(1) Administration of one drug can speed up the metabolism of another drug. Animal experiments show that this results from the ability of drugs to induce the synthesis of drug-metabolizing enzymes in liver microsomes. This effect has considerable importance in pharmacologic and toxicologic studies carried out in animals, and recent work indicates that it may explain altered therapeutic responses observed in some patients when they receive several drugs at the same time. Substances present in the environment, such as the insecticides chlordane and DDT, have been shown in animals to stimulate drug-metabolizing enzymes in liver, but the significance of this observation for man is not known. Drugs which stimulate drug metabolism also enhance the hydroxylation of testosterone, estradiol, progesterone and cortisol by enzymes in liver microsomes. Further research is required to establish the physiological importance of this interaction of drugs in steroid metabolism.(2) One drug may inhibit the metabolism of another drug and thus intensify and prolong its pharmacologic action. Although this effect is well documented in animals, recent reports suggest that this may also be important in man. For instance, the action of coumarin anticoagulants can be potentiated by administration of certain drugs which inhibit their metabolism. Monoamine oxidase inhibitors block the metabolism of certain sympathomimetic amines and this can lead to serious side-effects. Thus, hypertensive crises have been observed in patients receiving monoamine oxidase inhibitors who have eaten cheese with a high tyramine content.

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 4159124      PMCID: PMC1898669     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN: 0035-9157


  14 in total

1.  The clinical consequences of chronic hepatic enzyme induction by anticonvulsant drugs.

Authors:  A Richens
Journal:  Br J Clin Pharmacol       Date:  1974-06       Impact factor: 4.335

2.  Differences in pituitary and testicular function between diabetic patients on insulin and oral anti-diabetic agents.

Authors:  M M Shahwan; G S Spathis; D E Fry; P J Wood; V Marks
Journal:  Diabetologia       Date:  1978-07       Impact factor: 10.122

Review 3.  A modern view of pharmacokinetics.

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1973-10

Review 4.  [Drugs interacting with coumarine oral anticoagulants (author's transl)].

Authors:  R Gugler; H J Dengler
Journal:  Klin Wochenschr       Date:  1973-11-15

Review 5.  The interaction of drugs, with particular reference to anaesthetic practice.

Authors:  L C Jenkins
Journal:  Can Anaesth Soc J       Date:  1968-03

6.  Anaesthetic problems due to drug abuse and dependence.

Authors:  L C Jenkins
Journal:  Can Anaesth Soc J       Date:  1972-09

7.  Some potential interactions between prescribed drugs and over-the-counter drug products.

Authors:  J N Turner
Journal:  Calif Med       Date:  1972-09

8.  Drug displacement from protein binding: isolation of a redistributional drug interaction in vivo.

Authors:  E G McQueen; W M Wardell
Journal:  Br J Pharmacol       Date:  1971-10       Impact factor: 8.739

9.  Analysis of measurement data. Errors in providing data for statistical analysis.

Authors:  B W Cromie
Journal:  Proc R Soc Med       Date:  1966

10.  Genetic control of phenylbutazone metabolism in man.

Authors:  J A Whittaker; D A Evans
Journal:  Br Med J       Date:  1970-11-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.